158 related articles for article (PubMed ID: 33155445)
1. [Endovascular treatment of femoropopliteal arterial occlusive disease].
Kerzmann A; Boesmans E; Holemans C; Quaniers J; Alexandrescu V; Defraigne JO
Rev Med Liege; 2020 Nov; 75(11):717-723. PubMed ID: 33155445
[TBL] [Abstract][Full Text] [Related]
2. Network Analysis of Endovascular Treatment Strategies for Femoropopliteal Arterial Occlusive Disease.
Zhao S; Li L; Cui K
J Endovasc Ther; 2023 Aug; 30(4):487-498. PubMed ID: 35392691
[TBL] [Abstract][Full Text] [Related]
3. Drug-coated balloons versus drug-eluting stents in the femoropopliteal artery: comparing apples to oranges?
Ansel GM
J Cardiovasc Surg (Torino); 2019 Aug; 60(4):456-459. PubMed ID: 30994309
[TBL] [Abstract][Full Text] [Related]
4. Endovascular treatment of femoropopliteal arterial occlusive disease: Current techniques and limitations.
Aru RG; Tyagi SC
Semin Vasc Surg; 2022 Jun; 35(2):180-189. PubMed ID: 35672108
[TBL] [Abstract][Full Text] [Related]
5. The current state of surgical bypass versus drug eluting stents for long femoropopliteal occlusive lesions.
Yanagisawa W; Gomes ML; Menting TP; De Loose KR; Varcoe RL
J Cardiovasc Surg (Torino); 2019 Aug; 60(4):450-455. PubMed ID: 31062570
[TBL] [Abstract][Full Text] [Related]
6. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
[TBL] [Abstract][Full Text] [Related]
7. Comparison Between Interwoven Nitinol and Drug Eluting Stents for Endovascular Treatment of Femoropopliteal Artery Disease.
Haine A; Schmid MJ; Schindewolf M; Lenz A; Bernhard SM; Drexel H; Baumgartner I; Dopheide JF
Eur J Vasc Endovasc Surg; 2019 Dec; 58(6):865-873. PubMed ID: 31668949
[TBL] [Abstract][Full Text] [Related]
8. Bidirectional endovascular treatment for chronic total occlusive lesions of the femoropopliteal arterial segment using a hand-carried ultrasound device and a retrograde microcatheter.
Nishino M; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
J Vasc Surg; 2012 Jul; 56(1):113-7. PubMed ID: 22503184
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of combined superficial femoral artery endovascular therapy with popliteal-to-distal bypass: A paradigm shift in surgical open bypass for chronic limb-threatening ischemia.
Kobayashi T; Hamamoto M; Okazaki T; Hasegawa M; Fujiwara T; Takahashi S
Vascular; 2021 Dec; 29(6):905-912. PubMed ID: 33349196
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness Study of Drug-Eluting and Bare-Metal Peripheral Artery Stents in Endovascular Femoropopliteal Artery Revascularization.
Jeon-Slaughter H; Khalili H; Tsai S; Armstrong EJ; Shammas NW; Jawaid O; Lu H; Addo T; Gigliotti O; Abu-Fadel M; Banerjee S
J Invasive Cardiol; 2018 Oct; 30(10):373-379. PubMed ID: 30279293
[TBL] [Abstract][Full Text] [Related]
11. [Stent-assisted recanalization of femoropopliteal arterial occlusive disease. Influence of stent design on patency rates].
Treitl M; Reiser MF; Treitl KM
Radiologe; 2016 Mar; 56(3):233-9. PubMed ID: 26842999
[TBL] [Abstract][Full Text] [Related]
12. Algorithm of Femoropopliteal Endovascular Treatment.
Dubosq M; Raux M; Nasr B; Gouëffic Y
Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143968
[TBL] [Abstract][Full Text] [Related]
13. Evolution of patency rates of self-expandable bare metal stents for endovascular treatment of femoro-popliteal arterial occlusive disease: Does stent design matter?
Treitl KM; Woerner B; Schinner R; Czihal M; Notohamiprodjo S; Hoffmann U; Treitl M
Eur Radiol; 2017 Sep; 27(9):3947-3955. PubMed ID: 28168366
[TBL] [Abstract][Full Text] [Related]
14. Comparative Effectiveness of Endovascular Treatment Modalities for De Novo Femoropopliteal Lesions: A Network Meta-analysis of Randomized Controlled Trials.
Zhou Y; Zhang Z; Lin S; Xiao J; Ai W; Wang J; Li Y; Li Q
J Endovasc Ther; 2020 Feb; 27(1):42-59. PubMed ID: 31948375
[No Abstract] [Full Text] [Related]
15. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
Ascher E; Marks NA; Hingorani AP; Schutzer RW; Mutyala M
J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of polymer-free, paclitaxel-coated stents vs stent grafts in peripheral arterial disease patients with femoropopliteal artery lesions.
Tsujimura T; Takahara M; Iida O; Soga Y; Katsuki T; Fujihara M; Kawasaki D; Kozuki A; Mano T
J Vasc Surg; 2021 Jun; 73(6):1998-2008.e1. PubMed ID: 33347998
[TBL] [Abstract][Full Text] [Related]
17. Comparative Efficacy and Safety of Endovascular Treatment Modalities for Femoropopliteal Artery Lesions: A Network Meta-analysis of Randomized Controlled Trials.
Zhou Y; Zhang Z; Lin S; Xiao J; Ai W; Wang J; Li Y; Li Q
Cardiovasc Intervent Radiol; 2020 Feb; 43(2):204-214. PubMed ID: 31646376
[TBL] [Abstract][Full Text] [Related]
18. Device Selection in Femoral-Popliteal Arterial Interventions.
Kim SM; Kim LK; Feldman DN
Interv Cardiol Clin; 2020 Apr; 9(2):197-206. PubMed ID: 32147120
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions in intermittent claudication: A network meta-analysis of randomized controlled trials.
Zhou Y; Wang J; He H; Li Q; Li M; Li X; Shu C
Int J Cardiol; 2021 Nov; 343():122-130. PubMed ID: 34461162
[TBL] [Abstract][Full Text] [Related]
20. New stents for SFA.
MINAR E; SCHILLINGER M
J Cardiovasc Surg (Torino); 2009 Oct; 50(5):635-45. PubMed ID: 19741579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
